SE9703378D0 - New compounds - Google Patents

New compounds

Info

Publication number: SE9703378D0
Authority: SE; Sweden
Prior art keywords: alkyl; cycloalkyl; substituted; enantiomers; aryl
Prior art date: 1997-09-18

Application number

SE9703378A

Other languages

English (en)

Swedish (sv)

Inventor

Stefan Berg

Mats Linderberg

Svante Ross

Seth-Olov Thorberg

Bengt Ulff

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-18

Filing date

1997-09-18

Publication date

1997-09-18

1997-09-18 Application filed by Astra Ab filed Critical Astra Ab

1997-09-18 Priority to SE9703378A priority Critical patent/SE9703378D0/xx

1997-09-18 Publication of SE9703378D0 publication Critical patent/SE9703378D0/xx

1998-08-27 Priority to ZA987806A priority patent/ZA987806B/xx

1998-09-09 Priority to TR2000/00737T priority patent/TR200000737T2/xx

1998-09-09 Priority to AU91933/98A priority patent/AU9193398A/en

1998-09-09 Priority to SK287-2000A priority patent/SK2872000A3/sk

1998-09-09 Priority to CA002303926A priority patent/CA2303926A1/en

1998-09-09 Priority to PL98339661A priority patent/PL339661A1/xx

1998-09-09 Priority to KR1020007002824A priority patent/KR20010024078A/ko

1998-09-09 Priority to JP2000511762A priority patent/JP4002392B2/ja

1998-09-09 Priority to HR20000133A priority patent/HRP20000133A2/hr

1998-09-09 Priority to BR9812239-8A priority patent/BR9812239A/pt

1998-09-09 Priority to PCT/SE1998/001604 priority patent/WO1999014213A1/en

1998-09-09 Priority to EEP200000144A priority patent/EE200000144A/xx

1998-09-09 Priority to AT98944378T priority patent/ATE255099T1/de

1998-09-09 Priority to EP98944378A priority patent/EP1025096B1/de

1998-09-09 Priority to IL13507498A priority patent/IL135074A0/xx

1998-09-09 Priority to DE69820103T priority patent/DE69820103T2/de

1998-09-09 Priority to US09/171,572 priority patent/US6387899B1/en

1998-09-09 Priority to HU0100276A priority patent/HUP0100276A3/hu

1998-09-09 Priority to CN98811095A priority patent/CN1278809A/zh

1998-09-17 Priority to ARP980104637A priority patent/AR016651A1/es

2000-03-14 Priority to IS5403A priority patent/IS5403A/is

2000-03-17 Priority to NO20001403A priority patent/NO20001403L/no

2000-08-31 Priority to US09/653,552 priority patent/US6384225B1/en

Links

150000001875 compounds Chemical class 0.000 title abstract 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
125000001072 heteroaryl group Chemical group 0.000 abstract 2
125000005842 heteroatom Chemical group 0.000 abstract 2
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
125000000520 N-substituted aminocarbonyl group Chemical group [*]NC(=O)* 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 abstract 1
125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
-1 piperazinyl-substituted-3,4-dihydro-2H-1-benzopyran Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Obesity (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

SE9703378A 1997-09-18 1997-09-18 New compounds SE9703378D0 (sv)

Priority Applications (24)

Application Number	Priority Date	Filing Date	Title
SE9703378A SE9703378D0 (sv)	1997-09-18	1997-09-18	New compounds
ZA987806A ZA987806B (en)	1997-09-18	1998-08-27	Substituted chroman derivatives
CN98811095A CN1278809A (zh)	1997-09-18	1998-09-09	取代的苯并二氢吡喃衍生物
BR9812239-8A BR9812239A (pt)	1997-09-18	1998-09-09	Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
AT98944378T ATE255099T1 (de)	1997-09-18	1998-09-09	Substituierte chromanderivate
SK287-2000A SK2872000A3 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
CA002303926A CA2303926A1 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
PL98339661A PL339661A1 (en)	1997-09-18	1998-09-09	Substituted derivatives of chromane
KR1020007002824A KR20010024078A (ko)	1997-09-18	1998-09-09	치환된 크로만 유도체
JP2000511762A JP4002392B2 (ja)	1997-09-18	1998-09-09	置換されたクロマン誘導体
HR20000133A HRP20000133A2 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
TR2000/00737T TR200000737T2 (tr)	1997-09-18	1998-09-09	İkame edilmiş kroman türevleri.
PCT/SE1998/001604 WO1999014213A1 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
EEP200000144A EE200000144A (et)	1997-09-18	1998-09-09	Asendatud kromaani derivaadid
AU91933/98A AU9193398A (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
EP98944378A EP1025096B1 (de)	1997-09-18	1998-09-09	Substituierte chromanderivate
IL13507498A IL135074A0 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
DE69820103T DE69820103T2 (de)	1997-09-18	1998-09-09	Substituierte chromanderivate
US09/171,572 US6387899B1 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives
HU0100276A HUP0100276A3 (en)	1997-09-18	1998-09-09	Substituted chroman derivatives, process for their preparation and medicaments containing them
ARP980104637A AR016651A1 (es)	1997-09-18	1998-09-17	Derivados de 3,4-dihidro-2h-1-benzopirano substituidos con piperidinilo o piperazinilo, proceso para su preparacion, compuestos para su exclusivo uso endicho proceso, formulaciones farmaceuticas que comprenden dichos derivados y su uso para la elaboracion de un medicamento
IS5403A IS5403A (is)	1997-09-18	2000-03-14	Útskiptar króman afleiður
NO20001403A NO20001403L (no)	1997-09-18	2000-03-17	Substituerte kromanderivater
US09/653,552 US6384225B1 (en)	1997-09-18	2000-08-31	Intermediates in the preparation of substituted chroman derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9703378A SE9703378D0 (sv)	1997-09-18	1997-09-18	New compounds

Publications (1)

Publication Number	Publication Date
SE9703378D0 true SE9703378D0 (sv)	1997-09-18

Family

ID=20408298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9703378A SE9703378D0 (sv)	1997-09-18	1997-09-18	New compounds

Country Status (23)

Country	Link
US (2)	US6387899B1 (de)
EP (1)	EP1025096B1 (de)
JP (1)	JP4002392B2 (de)
KR (1)	KR20010024078A (de)
CN (1)	CN1278809A (de)
AR (1)	AR016651A1 (de)
AT (1)	ATE255099T1 (de)
AU (1)	AU9193398A (de)
BR (1)	BR9812239A (de)
CA (1)	CA2303926A1 (de)
DE (1)	DE69820103T2 (de)
EE (1)	EE200000144A (de)
HR (1)	HRP20000133A2 (de)
HU (1)	HUP0100276A3 (de)
IL (1)	IL135074A0 (de)
IS (1)	IS5403A (de)
NO (1)	NO20001403L (de)
PL (1)	PL339661A1 (de)
SE (1)	SE9703378D0 (de)
SK (1)	SK2872000A3 (de)
TR (1)	TR200000737T2 (de)
WO (1)	WO1999014213A1 (de)
ZA (1)	ZA987806B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9703377D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
MXPA03006268A (es)	2001-01-16	2003-09-22	Astrazeneca Ab	Compuestos terapeuticos de cromano.
NZ535574A (en)	2001-01-16	2006-07-28	Astrazeneca Ab	Therapeutic heterocyclic compounds
CA2434015A1 (en) *	2001-01-16	2002-07-18	Astrazeneca Ab	Therapeutic chroman compounds
WO2002066454A1 (fr) *	2001-02-21	2002-08-29	Sankyo Company, Limited	Derives de chromene
US7504395B2 (en)	2001-07-20	2009-03-17	Psychogenics, Inc.	Treatment for attention-deficit hyperactivity disorder
GB0124020D0 (en) *	2001-10-05	2001-11-28	Astrazeneca Ab	Chemical compounds
ITTO20030140U1 (it) *	2003-09-16	2005-03-17	Interfila Srl	Matita cosmetica
WO2005033092A1 (en)	2003-09-19	2005-04-14	Galileo Pharmaceuticals, Inc.	Chroman derivatives
US20050165025A1 (en) *	2004-01-22	2005-07-28	Recordati Ireland Ltd.	Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
KR100681453B1 (ko) *	2005-03-22	2007-02-12	태남자동화기기 주식회사	권종 분류 기능을 구비한 지폐 방출기
US9066903B2 (en)	2006-02-28	2015-06-30	The United States Of America As Represented By The Department Of Veterans Affairs	Pharmacological treatment of Parkinson's disease
WO2008130321A2 (en) *	2007-04-23	2008-10-30	Astrazeneca Ab	Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
WO2008130323A1 (en) *	2007-04-23	2008-10-30	Astrazeneca Ab	Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
SA08290245B1 (ar) *	2007-04-23	2012-02-12	استرازينيكا ايه بي	مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
WO2008130322A1 (en) *	2007-04-23	2008-10-30	Astrazeneca Ab	Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
WO2008130319A2 (en) *	2007-04-23	2008-10-30	Astrazeneca Ab	Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU627027B2 (en)	1989-04-27	1992-08-13	Pharmacia & Upjohn Company	Substituted 3-amino chromans
US5420151A (en)	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
SE8904361D0 (sv)	1989-12-22	1989-12-22	Astra Ab	New chroman and thiochroman derivatives
WO1997007120A1 (en) *	1995-08-11	1997-02-27	Smithkline Beecham Plc	Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists

1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 EP EP98944378A patent/EP1025096B1/de not_active Expired - Lifetime
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/en not_active Ceased
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 CA CA002303926A patent/CA2303926A1/en not_active Abandoned
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Withdrawn
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/xx unknown
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
2000
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2303926A1 (en)	1999-03-25
PL339661A1 (en)	2001-01-02
BR9812239A (pt)	2000-07-18
US6387899B1 (en)	2002-05-14
JP2001516755A (ja)	2001-10-02
SK2872000A3 (en)	2000-11-07
EE200000144A (et)	2001-02-15
HUP0100276A2 (hu)	2002-05-29
WO1999014213A1 (en)	1999-03-25
IL135074A0 (en)	2001-05-20
US6384225B1 (en)	2002-05-07
ATE255099T1 (de)	2003-12-15
KR20010024078A (ko)	2001-03-26
IS5403A (is)	2000-03-14
NO20001403D0 (no)	2000-03-17
ZA987806B (en)	1999-03-18
EP1025096B1 (de)	2003-11-26
HRP20000133A2 (en)	2001-12-31
DE69820103T2 (de)	2004-09-02
CN1278809A (zh)	2001-01-03
HUP0100276A3 (en)	2002-08-28
AU9193398A (en)	1999-04-05
JP4002392B2 (ja)	2007-10-31
EP1025096A1 (de)	2000-08-09
DE69820103D1 (de)	2004-01-08
TR200000737T2 (tr)	2000-09-21
NO20001403L (no)	2000-05-18
AR016651A1 (es)	2001-07-25

Publication	Publication Date	Title
SE9702799D0 (sv)	1997-07-25	New compounds
SE9703377D0 (sv)	1997-09-18	New compounds
NZ331613A (en)	2000-03-27	Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives
AR025975A1 (es)	2002-12-26	Compuestos quimicos.
DE69523169D1 (de)	2001-11-15	Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
CA2011346A1 (en)	1990-09-03	2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
SE0101579D0 (sv)	2001-05-04	New compounds
BR9812239A (pt)	2000-07-18	Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
DZ1694A1 (fr)	2002-02-17	"n-(2-Aminoethyl)-benzothialozones".
SE8301412D0 (sv)	1983-03-15	Substituerade 1h-pyrazolo(1,5)pyrimidiner och forfarande for deras framstellning
CA1272482C (en)	1990-08-07	QUINOLINECARBOXYLIC ACID DERIVATIVES
DK0565377T3 (da)	1998-03-16	Terapeutiske midler til behandling af Parkinsons sygdom
BG94282A (bg)	1993-12-24	2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
NO152047C (no)	1985-07-24	Analogifremgangsmaate for fremstilling av terapeutisk virksom 5-(paradeuterofenyl)-5-fenylhydantoin
ES2012648A6 (es)	1990-04-01	Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
MY140653A (en)	2010-01-15	Substituted diketopiperazines and their use as oxytocyn antagonists
NO961797L (no)	1996-11-06	Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
DK1161424T3 (da)	2004-09-13	Hidtil ukendte diazolderivater som serotonerge midler
YU16196A (sh)	1998-11-05	Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka
TR200103286T2 (tr)	2002-07-22	Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri
HUP0203696A2 (hu)	2003-03-28	Sejtburjánzásgátló hatású helyettesített bisz-indolil-maleimidek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20020475L (no)	2002-03-13	2-aminotetralinderivater for terapi av glaukom
HUP0202663A2 (hu)	2002-12-28	7-acilamino-3-heteroariltio-3-cefémkarbonsav antibiotikumok és prodrogjaik, előállításuk és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60121817D1 (de)	2006-09-07	Blockade der natriumkanäle durch phenolderivate
YU28701A (sh)	2003-12-31	N-(2-(heteroaril)etil)-3-fenilpiperidini, n-(2-(heteroaril) etil)-4-fenilpiperidin i srodna jedinjenja sa supstituentom u položaju 4 piperidinskog prstena

SE9703378D0 - New compounds - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (24)

Applications Claiming Priority (1)

Publications (1)

Family

ID=20408298

Family Applications (1)

Country Status (23)

Families Citing this family (18)

Family Cites Families (4)

Also Published As

Similar Documents